Vivacta, a UK-based developer of a blood-drop test for thyroid functionality, has raised $4.5 million in new VC funding. Return backers included AGF Private Equity, HBM Bioventures, Spark Ventures and Viking Technologies.
Vivacta, a UK-based developer of a blood-drop test for thyroid functionality, has raised $4.5 million in new VC funding. Return backers included AGF Private Equity, HBM Bioventures, Spark Ventures and Viking Technologies.
